Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://endpts.com/aeglea-rebrands-to-spyre-names-new-ceo-in-ibd-race-against-tl1a-drugs-at-merck-roche-and-sanofi/
https://www.prnewswire.com/news-releases/aeglea-biotherapeutics-announces-name-change-to-spyre-therapeutics-appoints-ceo-and-additional-directors-and-expands-leadership-team-to-develop-next-generation-therapeutic-combinations-for-the-treatment-of-ibd-301996712.html
https://www.prnewswire.com/news-releases/aeglea-biotherapeutics-announces-sale-of-pegzilarginase-to-immedica-pharma-301887231.html
https://www.fiercebiotech.com/biotech/immedica-takes-embattled-rare-disease-asset-aegleas-hands-15m-cash
https://www.prnewswire.com/news-releases/aeglea-biotherapeutics-announces-acquisition-of-spyre-therapeutics-301858013.html
https://www.biopharmadive.com/news/spyre-aeglea-reverse-merger-paragon-tl1a-ibd/653672/
https://www.fiercebiotech.com/biotech/faced-rocky-interim-data-aeglea-lays-more-staff-and-seeks-exit-route
https://www.fiercebiotech.com/biotech/aeglea-cuts-curb-spending-q4-cash-crunch-still-cards
https://www.prnewswire.com/news-releases/aeglea-biotherapeutics-appoints-linda-neuman-md-mba-to-chief-medical-officer-301679208.html
https://www.prnewswire.com/news-releases/aeglea-biotherapeutics-reports-third-quarter-2022-financial-results-and-provides-program-updates-301667153.html